Literature DB >> 26770507

The clinical comparative study on high and low viscosity bone cement application in vertebroplasty.

Teng-Hui Zeng1, Yi-Ming Wang2, Xin-Jian Yang1, Jian-Yi Xiong1, Dai-Qi Guo1.   

Abstract

OBJECTIVE: To investigate the clinical effect of high and low viscosity bone cement in vertebroplasty for treatment of osteoporotic vertebral compression fractures.
METHODS: 40 cases of patients with osteoporotic thoracolumbar compression fractures admitted into department of orthopeadics in our hospital were reviewed. All patients were divided into high viscosity bone cement group (20 cases) and low viscosity bone cement group (20 cases). Visual Analog Score (VAS), Oswestry Dability Index (ODI), injured vertebral height restoration (Cobb Angle) and bone cement leakage rate, subsequent fracture rate of vertebrae body with or without surgical treatment were measured.
RESULTS: Compared with the low viscosity bone cement group, the VAS score, ODI score and Cobb angle of high viscosity bone cement group had a statistical difference (P<0.05). The postoperative complications in high viscosity bone cement group were lower than those in low viscosity bone cement group (P<0.05).
CONCLUSION: Compared with low viscosity bone cement, bone cement leakage rate reduced obviously in high viscosity bone cement with good clinical effect and prognosis in vertebroplasty for treatment of osteoporotic thoracolumbar compression fractures.

Entities:  

Keywords:  Vertebroplasty; compression fracture; high viscosity bone cement; osteoporosis; spinal fracture

Year:  2015        PMID: 26770507      PMCID: PMC4694407     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  15 in total

Review 1.  Painful osteoporotic vertebral fracture. Pathogenesis, evaluation, and roles of vertebroplasty and kyphoplasty in its management.

Authors:  Raj D Rao; Manoj D Singrakhia
Journal:  J Bone Joint Surg Am       Date:  2003-10       Impact factor: 5.284

Review 2.  Complications of percutaneous vertebroplasty and their prevention.

Authors:  Jean-Denis Laredo; Bassam Hamze
Journal:  Semin Ultrasound CT MR       Date:  2005-04       Impact factor: 1.875

3.  Osteoporotic compression fractures: outcomes after single- versus multiple-level percutaneous vertebroplasty.

Authors:  Anand K Singh; Thomas K Pilgram; Louis A Gilula
Journal:  Radiology       Date:  2006-01       Impact factor: 11.105

4.  Percutaneous vertebroplasty and bone cement leakage: clinical experience with a new high-viscosity bone cement and delivery system for vertebral augmentation in benign and malignant compression fractures.

Authors:  Giovanni Carlo Anselmetti; Gregg Zoarski; Antonio Manca; Salvatore Masala; Haris Eminefendic; Filippo Russo; Daniele Regge
Journal:  Cardiovasc Intervent Radiol       Date:  2008-04-04       Impact factor: 2.740

5.  Percutaneous vertebroplasty for vertebral compression fractures with and without intravertebral clefts.

Authors:  K-Y Ha; J-S Lee; K-W Kim; J-S Chon
Journal:  J Bone Joint Surg Br       Date:  2006-05

Review 6.  Properties of osteoconductive biomaterials: calcium phosphates.

Authors:  Racquel Zapanta LeGeros
Journal:  Clin Orthop Relat Res       Date:  2002-02       Impact factor: 4.176

7.  Analysis of adjacent fracture after percutaneous vertebroplasty: does intradiscal cement leakage really increase the risk of adjacent vertebral fracture?

Authors:  Kyung-Ah Lee; Suk-Joo Hong; Seunghun Lee; In Ho Cha; Baek-Hyun Kim; Eun-Young Kang
Journal:  Skeletal Radiol       Date:  2011-03-12       Impact factor: 2.199

8.  Long-term follow-up of vertebral osteoporotic fractures treated by percutaneous vertebroplasty.

Authors:  Isabelle Legroux-Gérot; Christian Lormeau; Nathalie Boutry; Anne Cotten; Bernard Duquesnoy; Bernard Cortet
Journal:  Clin Rheumatol       Date:  2004-05-18       Impact factor: 2.980

9.  Postprocedural CT for perivertebral cement leakage in percutaneous vertebroplasty is not necessary--results from VERTOS II.

Authors:  Alexander Venmans; Caroline A Klazen; Willem Jan van Rooij; Jolanda de Vries; Willem P Mali; Paul N Lohle
Journal:  Neuroradiology       Date:  2010-05-05       Impact factor: 2.804

10.  Cement leakage and filling pattern study of low viscous vertebroplastic versus high viscous confidence cement.

Authors:  Mohamed Habib; Hassan Serhan; Connie Marchek; Gamal Baroud
Journal:  SAS J       Date:  2010-03-01
View more
  6 in total

Review 1.  High- versus low-viscosity cement vertebroplasty and kyphoplasty for osteoporotic vertebral compression fracture: a meta-analysis.

Authors:  Qiang Wang; Changtai Sun; Liang Zhang; Lin Wang; Quan Ji; Nan Min; Zilong Yin
Journal:  Eur Spine J       Date:  2022-03-06       Impact factor: 2.721

2.  Comparison the clinical outcomes and complications of high-viscosity versus low-viscosity in osteoporotic vertebral compression fractures.

Authors:  Zhao Guo; Wei Wang; Wen-Shan Gao; Fei Gao; Hui Wang; Wen-Yuan Ding
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

3.  Treating osteoporotic vertebral compression fractures with intraosseous vacuum phenomena using high-viscosity bone cement via bilateral percutaneous vertebroplasty.

Authors:  Dan Guo; Jun Cai; Shengfei Zhang; Liang Zhang; Xinmin Feng
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

4.  Effects of Polymethylmethacrylate Cement Viscosity and Bone Porosity on Cement Leakage and New Vertebral Fractures After Percutaneous Vertebroplasty: A Prospective Study.

Authors:  Mohamed Alhashash; Mootaz Shousha; Ahmed Samir Barakat; Heinrich Boehm
Journal:  Global Spine J       Date:  2019-02-28

Review 5.  Application and modification of bone cement in vertebroplasty: A literature review.

Authors:  Qian Wang; Jun-Feng Dong; Xu Fang; Yang Chen
Journal:  Jt Dis Relat Surg       Date:  2022-07-06

6.  Percutaneous vertebroplasty with high- versus low-viscosity bone cement for osteoporotic vertebral compression fractures.

Authors:  Feng Miao; Xiaojun Zeng; Wei Wang; Zhou Zhao
Journal:  J Orthop Surg Res       Date:  2020-08-06       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.